Patients Treated with ARIKAYCE plus macrolide-based background regimen had meaningfully larger improvements in QOL-B respiratory score
Robots make it to the healthcare conference panel, reflecting the future potential of technology
NIH’s candidate is based on the Adenovirus 4 backbone, largely used as a vector candidate in HIV and influenza vaccine clinical trials
Jupiter has filed its draft herring prospectus (DRHP) with the market regulator in May this year, to float its IPO
Combating the prevalent stigma against TB in the society, India has been committed to providing, enabling and patient-centric support to all, individuals suffering from TB
The identified products for Active Pharmaceutical Ingredients (API) will be developed under the CRAMS and CDMO models
Urges Innovators to produce quality products that can be deployed at scale
The Global Medical Countermeasures Platform will provide equal access safe, high-quality, cost-effective medical countermeasures to the world
The facility will have a capacity to manufacture upto 3 million tubes monthly
New high-tech facility in Biberach offers attractive workplaces for more than 500 scientists
Subscribe To Our Newsletter & Stay Updated
